Health House International Limited’s (ASX:HHI) wholly-owned subsidiary CanPharma GmbH has entered into an agreement with Hausärzteverband Nordrhein e.V (North Rhine Association of General Practitioners), to sponsor training related to medical cannabis.
The training will be carried out experts from Group company Kalapa Germany GmbH.
In Germany, the initial contact for accessing healthcare is normally a General Practitioner (GP). The North Rhine Association of General Practitioners represents over 2,500 GPs and is one of the 18 regional groups making up the Federal Association of GPs which represents more than 30,000 members and is the largest professional association of GPs in Germany.
CanPharma will be the first cannabis collaboration partner of the North Rhine Association of General Practitioners: a series of educational trainings for the GPs is planned for early 2022, both virtually as well as in person.
CanPharma Chief Executive Officer, and Health House Executive Director, Dr Henrik Sprengel, said the cooperation with the regional association of North Rhine is planned as a pilot project with a view to expand to other regional associations in the future.
We are very proud to have closed this cooperation with the German Association of General Practitioners,” Dr Sprengel said.
“For CanPharma, the well-being of the patient has the highest priority which is why we provide patients high-quality; moreover, we feel that this is also achieved by educating healthcare professionals with a solid foundation of knowledge on which to base their future prescriptions of medicinal cannabis.”
